Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hospital Departments | 1 | 2020 | 831 | 0.51 | Why? |
| Grief | 1 | 2017 | 320 | 0.47 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.43 | Why? |
| Cerebral Hemorrhage | 4 | 2020 | 820 | 0.43 | Why? |
| Neurology | 1 | 2020 | 1613 | 0.36 | Why? |
| Family | 1 | 2017 | 2909 | 0.25 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.24 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.23 | Why? |
| Brain Diseases, Metabolic | 1 | 2021 | 24 | 0.22 | Why? |
| Neuroscience Nursing | 1 | 2020 | 32 | 0.22 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2017 | 2963 | 0.21 | Why? |
| New York City | 7 | 2020 | 7432 | 0.20 | Why? |
| Comprehensive Health Care | 1 | 2020 | 153 | 0.19 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2020 | 203 | 0.17 | Why? |
| Safety-net Providers | 1 | 2020 | 302 | 0.17 | Why? |
| Leukoencephalopathies | 1 | 2020 | 230 | 0.17 | Why? |
| Hyponatremia | 1 | 2020 | 371 | 0.16 | Why? |
| Stroke | 4 | 2020 | 8839 | 0.15 | Why? |
| Ethics, Clinical | 1 | 2017 | 93 | 0.15 | Why? |
| Brain Death | 1 | 2017 | 146 | 0.15 | Why? |
| Quality Indicators, Health Care | 1 | 2020 | 580 | 0.14 | Why? |
| Hospitals, Urban | 1 | 2020 | 950 | 0.14 | Why? |
| Death | 1 | 2017 | 334 | 0.13 | Why? |
| Electroencephalography | 1 | 2020 | 1242 | 0.13 | Why? |
| Brain Diseases | 2 | 2021 | 1463 | 0.12 | Why? |
| Thrombophilia | 2 | 2021 | 1935 | 0.11 | Why? |
| Thrombolytic Therapy | 2 | 2020 | 2218 | 0.11 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.10 | Why? |
| Recovery of Function | 2 | 2018 | 2461 | 0.10 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.09 | Why? |
| Blood Sedimentation | 2 | 2021 | 508 | 0.09 | Why? |
| Thrombectomy | 1 | 2020 | 2272 | 0.09 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.09 | Why? |
| Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.09 | Why? |
| Patient Admission | 3 | 2020 | 5250 | 0.09 | Why? |
| Quality Improvement | 1 | 2020 | 2435 | 0.08 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Disability Evaluation | 2 | 2018 | 671 | 0.07 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.07 | Why? |
| Machine Learning | 2 | 2021 | 4395 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.07 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Neuroimaging | 2 | 2020 | 1106 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Aged | 13 | 2021 | 215776 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.06 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.05 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.05 | Why? |
| Neurotoxicity Syndromes | 1 | 2020 | 124 | 0.05 | Why? |
| Partial Thromboplastin Time | 1 | 2021 | 436 | 0.05 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.05 | Why? |
| Spinal Cord Diseases | 1 | 2020 | 141 | 0.05 | Why? |
| Carotid Artery, Internal | 1 | 2020 | 97 | 0.05 | Why? |
| Patient Discharge | 3 | 2020 | 5696 | 0.05 | Why? |
| Cerebral Small Vessel Diseases | 1 | 2020 | 89 | 0.05 | Why? |
| Mechanical Thrombolysis | 1 | 2020 | 150 | 0.05 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.05 | Why? |
| Male | 13 | 2021 | 367725 | 0.04 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.04 | Why? |
| Cerebral Angiography | 1 | 2020 | 391 | 0.04 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2018 | 249 | 0.04 | Why? |
| Carotid Stenosis | 1 | 2020 | 207 | 0.04 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.04 | Why? |
| Humans | 18 | 2021 | 930598 | 0.04 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Ohio | 1 | 2018 | 639 | 0.04 | Why? |
| Causality | 1 | 2020 | 857 | 0.04 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2018 | 219 | 0.04 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.04 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.04 | Why? |
| Fibrinogen | 1 | 2021 | 1048 | 0.04 | Why? |
| Resuscitation Orders | 1 | 2017 | 188 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.03 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.03 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.03 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.03 | Why? |
| Tissue Plasminogen Activator | 1 | 2020 | 778 | 0.03 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Interleukin-6 | 2 | 2021 | 7522 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2021 | 1530 | 0.03 | Why? |
| New York | 1 | 2020 | 2488 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Adult | 5 | 2020 | 244371 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.03 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.03 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.02 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.02 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Myocardial Infarction | 1 | 2021 | 3361 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.01 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Lord's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(193)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_